ASX - By Stock
|
MYX |
Re:
News: MYX Mithra Says Sells Shares In Mayne Pharma
|
|
mikyc
|
59 |
19K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
59
|
19K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
share offload
|
|
mikyc
|
11 |
3.0K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
11
|
3.0K
|
0
|
|
ASX - By Stock
|
MYX |
share offload
|
|
mikyc
|
11 |
3.0K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
11
|
3.0K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Risk Assessment
|
|
mikyc
|
38 |
12K |
3 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mikyc
|
15 |
4.4K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
15
|
4.4K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Risk Assessment
|
|
mikyc
|
38 |
12K |
0 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
38
|
12K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
mikyc
|
8 |
1.9K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
1.9K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
mikyc
|
8 |
1.9K |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
1.9K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
mikyc
|
8 |
1.9K |
4 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
1.9K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Notice of Extraordinary General Meeting / Proxy Form
|
|
mikyc
|
34 |
8.5K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
34
|
8.5K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
mikyc
|
6 |
2.9K |
5 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
6
|
2.9K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
1 |
432 |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
1
|
432
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Notice of Extraordinary General Meeting / Proxy Form
|
|
mikyc
|
34 |
8.5K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
34
|
8.5K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Voluntary Suspension
|
|
mikyc
|
20 |
7.5K |
3 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
20
|
7.5K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Shareholder Update - Restructuring Transaction
|
|
mikyc
|
8 |
4.2K |
6 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
8
|
4.2K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
fair price $8.22
|
|
mikyc
|
43 |
17K |
1 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
17K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Quarterly activities report and Appendix 4C - September 2023
|
|
mikyc
|
5 |
2.7K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
5
|
2.7K
|
3
|
|
ASX - By Stock
|
CBA |
Re:
News: CBA CBA Expands Its Anti-Scam Technologies
|
|
mikyc
|
1 |
338 |
0 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
1
|
338
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Change of Director's Interest Notice
|
|
mikyc
|
22 |
6.7K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
22
|
6.7K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Quarterly activities report and Appendix 4C - September 2023
|
|
mikyc
|
5 |
2.7K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
5
|
2.7K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
fair value 8.08
|
|
mikyc
|
4 |
1.7K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
4
|
1.7K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
42
|
11K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
42
|
11K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
6 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
11K |
4 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
11K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
1 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
23
|
10K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Mayne Pharma sees strong sales growth in FY 2023
|
|
mikyc
|
77 |
19K |
3 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
77
|
19K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
12K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
61
|
12K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
12K |
1 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
61
|
12K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
12K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
61
|
12K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
12K |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
61
|
12K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
NEXTSTELLIS® ORAL CONTRACEPTIVE
|
|
mikyc
|
26 |
8.8K |
1 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
26
|
8.8K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
same asset value after selling Metrics and no debt
|
|
mikyc
|
12 |
3.3K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
12
|
3.3K
|
1
|
|
ASX - By Stock
|
MYX |
Require Pesticide
|
|
mikyc
|
0 |
194 |
0 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
0
|
194
|
0
|
|
ASX - By Stock
|
MYX |
Re:
BOOK value $7.60 per share
|
|
mikyc
|
28 |
5.3K |
5 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
28
|
5.3K
|
5
|
|
ASX - By Stock
|
MDC |
Re:
News: MDC Medlab Clinical Says Aware Of Email Regarding Expressions Of Interest For Broadcast
|
|
mikyc
|
1 |
1.1K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
1
|
1.1K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
7 |
2.5K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
7
|
2.5K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma executes asset purchase agreement for Rhofade
|
|
mikyc
|
7 |
2.0K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Disintermediation Strategy,
|
|
mikyc
|
4 |
873 |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
4
|
873
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma executes asset purchase agreement for Rhofade
|
|
mikyc
|
7 |
2.0K |
0 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Nexstllis growth 267% units sold 256330 units sold
|
|
mikyc
|
7 |
1.5K |
2 |
03/09/23 |
03/09/23 |
ASX - By Stock
|
7
|
1.5K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Disintermediation Strategy,
|
|
mikyc
|
4 |
873 |
0 |
03/09/23 |
03/09/23 |
ASX - By Stock
|
4
|
873
|
0
|
|